KIF23 and central nervous system cancer: Similarly, KIF23, as a key regulator of cytokinesis, is also found to be correlated with poor prognosis for patients with hepatocellular carcinoma (Sun et al., 2015), glioma (Sun et al., 2016), gastric cancer (Li et al., 2019), and non-small-cell lung cancer (Vikberg et al., 2017).